Stephanie Mack, Das Research Group, Department of Chemistry, Carnegie Mellon University
Location: Mellon Institute Room 355
Original Research Proposal: Creation of an Iron Sensing FXN mRNA Therapeutic Riboswitch for the Treatment of Friedreich's Ataxia